Defining and measuring recovery from myalgic encephalomyelitis and chronic fatigue syndrome: the physician perspective.
Devendorf AR et al. (2017) Defining and measuring recovery from […]
Devendorf AR et al. (2017) Defining and measuring recovery from […]
Roerink ME et al. (2015) Cytokine inhibition in chronic fatigue
Roerink ME et al. (2017) Cytokine signatures in chronic fatigue
Rowe KS. (1997) Double-blind randomized controlled trial to assess the
Rowe PC et al. (2001) Fludrocortisone acetate to treat neurally
Royds J et al. (2019) An investigation into the modulation
Santaella ML et al. (2004) Comparison of oral nicotinamide adenine
Olmesartan alleviates symptoms of chronic fatigue syndrome in mice. Read More »
Saqulain S et al. (2022) Olmesartan alleviates symptoms of chronic
Alpha Interferon Treatment of Patients with Chronic Fatigue Syndrome. Read More »
See DM and Tilles JG . (1996) Alpha Interferon Treatment
Long-term treatment is being used Read More »
Shepherd C . (1997) Long-term treatment is being used .
Sp�th M et al. (2000) Treatment of chronic fatigue syndrome
Stanculescu D et al. (2021) Hypothesis: Mechanisms That Prevent Recovery
Staud R ,, et al. (2017) Muscle injections with lidocaine
St. Clair EW et al. (2013) Rituximab Therapy for Primary
Steinberg P et al. (1996) Double-blind placebo-controlled study of the
Strayer DR et al. (1994) A Controlled Clinical Trial with
Strayer DR et al. (2012) A Double-Blind, Placebo-Controlled, Randomized, Clinical
Strayer Dr et al. (2020). Effect of disease duration in
Straus SE et al. (1988) Acyclovir Treatment of the Chronic
Pharmacological significance of MitoQ in ameliorating mitochondria-related diseases. Read More »
Sulaim on LA et al. (2022) Pharmacological significance of MitoQ